Duramed Research
25
0
0
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
8.0%
2 terminated/withdrawn out of 25 trials
92.0%
+5.5% vs industry average
60%
15 trials in Phase 3/4
39%
9 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
A Safety Extension Study of DR-OXY-301
Role: lead
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
Role: lead
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
Role: lead
Intrauterine Device (IUD) Placement at the Time of Cesarean Section
Role: collaborator
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
Role: lead
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Role: lead
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
Role: lead
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
Role: lead
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
Role: lead
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
Role: lead
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Role: lead
Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement
Role: lead
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Role: lead
Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
Role: lead
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
Role: lead
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Role: lead
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
Role: lead
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
Role: lead
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
Role: lead
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Role: lead